Could viruses and epigenetics be the hidden cause of chronic sinusitis?
NCT ID NCT05857228
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates why some people develop chronic sinusitis with nasal polyps, focusing on how epigenetic changes and viruses might trigger the disease. Researchers will analyze tissue samples from 60 participants, including patients with active disease, those in remission, and healthy volunteers. The goal is to find new biomarkers and viral links that could lead to better treatments.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify new biomarkers and viral triggers for chronic sinusitis, pointing toward novel therapies.
- What could go wrong
- This is an observational study, not a treatment trial. It is small (60 participants) and early-stage, so findings may not lead to direct treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2023
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
* T2 CRSwNP patients with favorable evolution * T2 CRSwNP patients undergoing ESS * Healthy volonteers with no nasal symptoms and documented normal sense of smell
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * T2 CRSwNP patients with favorable evolution * T2 CRSwNP patients undergoing ESS * Healthy volonteers with no nasal symptoms and documented normal sense of smell Exclusion Criteria: * Cystic fibrosis * Primary immunodefisciencies
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic rhinosinusitis (diagnosis) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHUM
Montreal, Quebec, H2X 3E4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Viruses that kill bacteria: a new weapon against superbugs?
- Sugar alcohol rinse could soothe sinus pain in cystic fibrosis
- Could a cystic fibrosis drug ease stubborn sinus infections?
- New sinus implant aims to unblock noses and ease facial pain
- Sinus study pulled before it even started
- Scientists hunt for hidden bacteria behind chronic sinusitis